Biohackers could drive insulin price down 98 percent

A team of biohackers is on a David-versus-Goliath mission to make insulin affordable to an increasing number of diabetics.

Photo: Goffkein / Adobe Stock
  • Diabetes is the seventh-leading cause of death in America.
  • About 463 million people (including 34 million Americans) are diabetic.
  • The cost of insulin continues to surge, so the Open Insulin Project is fighting back by replicating medical-grade insulin that can be made at a lab in your neighborhood.
Keep reading Show less

Should scientific studies be available for free?

Plan S is starting to take hold, but the cost is merely shifting even more to the researchers.

Credit: yurolaitsalbert / Adobe Stock
  • Launched in 2018, cOAlition S is trying to make all of the world's state-backed scientific papers open-access.
  • Prestigious publishers like Springer Nature and Elsevier have now adopted a Plan S option for researchers.
  • While more studies will be available to read for free, some of the expense is being passed back to authors, which could limit research in the future.
Keep reading Show less

FDA requires new addiction warning on benzodiazepines

There has been a dramatic increase in abuse and misuse.

Credit: LMWH / Shutterstock
  • Benzodiazepine usage has increased in 2020 due to the pandemic.
  • The FDA is requiring new label warnings due to increased abuse and misuse of benzos.
  • Drugs like Valium and Xanax are approved for short-term use only, yet many are on them for years and even decades.
Keep reading Show less

The surprising future of vaccine technology

We owe a lot to vaccines and the scientists that develop them. But we've only just touched the surface of what vaccines can do.

  • "Vaccines are the best thing science has ever given us," says Larry Brilliant, founding president and acting chairman of Skoll Global Threats. From smallpox, to Ebola, to polio, scientists have successful fought viruses and saved millions of lives. So what's next?
  • As Covaxx (formerly United Neuroscience) cofounder Lou Reese explains in this video, the issue with vaccines is that they don't work against "non-external threats." This is a problem, especially now when internal threats (things that cause cancers, Alzheimer's, diabetes, and other chronic illnesses) are killing people more than external threats like viruses.
  • The future of vaccine tech, which scientists are already working toward today, is developing safe vaccines to eradicate these destructive internal agents without harming our bodies in the process.


Keep reading Show less

US, Russia, China won't join global initiative to offer fair access to COVID-19 vaccines. Why not?

The U.S., China, and Russia are in a "vaccine race" that treats a global challenge like a winner-take-all game.

  • More than 150 countries have joined an initiative to develop, produce, and fairly distribute an effective COVID-19 vaccine.
  • But China, Russia, and the U.S. have declined to join in a bid to win the vaccine race.
  • The absence of these three economies risks the success of the global initiative and future collaborations.
  • Keep reading Show less
    Quantcast